According to the latest data from the Hong Kong Stock Exchange, on May 6, Morgan Stanley increased its stake in Novosense (02676) by 34,100 shares, with an average price of HK$149.619 per share, resulting in a total transaction value of approximately HK$5.102 million. Following this acquisition, the latest shareholding stands at around 1.0382 million shares, representing a stake of 5.16%.